

Meet ourLeaders
Leadership Team
Cytokinetics is led by a team of seasoned industry veterans with the shared objective to create the next great biopharmaceutical company that has the potential to change patients’ lives. With significant depth of industry experience and highly complementary skills in diverse fields including drug discovery, clinical research, business development, and commercialization, we’re ready to address the challenges and opportunities of creating an organization committed to helping those affected by serious diseases.
Cytokinetics was founded by pioneers in the field of muscle biology. This team of forward-thinking scientists set out a vision for translating their expertise into new insights and approaches to novel drug discovery. Over the years, the Company has developed an unparalleled expertise, keeping it at the forefront of drug discovery and development for diseases impacting muscle performance.
Our MANAGEMENT TEAM
filter by:-
Robert I. Blum
President And Chief Executive Officer
-
Durga Bobba
VP, Global Franchise General Manager, Cardiovascular
-
Daniel R. Casper
VP, Information Technology
-
Bonnie A. Charpentier, Ph.D.
SVP, Regulatory Affairs and Compliance
-
David W. Cragg
Chief Human Resources & Administration Officer
-
Erin Donnelly
VP, Portfolio & Project Management
-
Ching W. Jaw
SVP, Chief Financial Officer
-
Scott R. Jordan
SVP, New Product Planning and Commercial Development
-
Daniel E. Kates, M.D., M.B.A.
VP, Medical Affairs
-
Stuart Kupfer, M.D.
SVP, Chief Medical Officer
-
Fady I. Malik, M.D., Ph.D.
EVP, Research and Development
-
Bradley P. Morgan, Ph.D.
SVP, Research and Non-Clinical Development
-
Anne N. Murphy, Ph.D.
VP, Biology
-
Mark A. Schlossberg, J.D.
SVP, Legal and General Counsel
-
Elisabeth A. Schnieders, Ph.D.
SVP, Business Development
-
Eric Terhaerdt
VP, Development Operations
-
Diane Weiser
SVP, Corporate Communications and Investor Relations
-
Andrew A. Wolff, M.D., FACC
SVP, Senior Fellow, Clinical Research and Development
-
Robert C. Wong
VP, Chief Accounting Officer
-
Robert I. Blum
Director
-
Robert Califf, M.D.
Director
-
Santo J. Costa
Director
-
L. Patrick Gage, Ph.D.
Chairman
-
John T. Henderson, M.D., Ch.B.
Director
-
Edward M. Kaye, M.D.
Director
-
B. Lynne Parshall, Esq
Director
-
Sandford D. Smith
Director
-
Wendell Wierenga, Ph.D.
Director
-
Nancy Wysenski
Director